Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126195902 | 12619590 | 2 | F | 20160822 | 20160803 | 20160830 | EXP | JP-PFIZER INC-2016370621 | PFIZER | FUNAKOSHI, Y.. A CASE OF PULMONARY MUCORMYCOSIS DURING IMATINIB-CONTAINING INDUCTION CHEMOTHERAPY FOR PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA. THE JAPANESE JOURNAL OF PEDIATRIC HEMATOLOGY / ONCOLOGY (2016.7). 2016;53:129-134 | 15.00 | YR | M | Y | 0.00000 | 20160830 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126195902 | 12619590 | 1 | PS | ADRIACIN | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 25 MG/M2, UNK | U | 0 | 25 | MG/M**2 | |||||||
| 126195902 | 12619590 | 2 | SS | LEUNASE | ASPARAGINASE | 1 | 2000 DF, UNK | U | 0 | 2000 | DF | INJECTION | |||||||
| 126195902 | 12619590 | 3 | SS | IMATINIB MESILATE | IMATINIB MESYLATE | 1 | Oral | 600 MG, UNK | U | 0 | 600 | MG | |||||||
| 126195902 | 12619590 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 1200 MG/M2, UNK | U | 0 | 1200 | MG/M**2 | INJECTION | ||||||
| 126195902 | 12619590 | 5 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 120 MG/KG, UNK | U | 0 | 120 | MG/KG | INJECTION | ||||||
| 126195902 | 12619590 | 6 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | 2 MG, UNK | U | 0 | 2 | MG | INJECTION | ||||||
| 126195902 | 12619590 | 7 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | 80 MG, UNK | U | 0 | 80 | MG | ||||||||
| 126195902 | 12619590 | 8 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | UNK MG, UNK | U | 0 | ||||||||||
| 126195902 | 12619590 | 9 | SS | DASATINIB | DASATINIB | 1 | Oral | 140 MG, UNK | U | 0 | 140 | MG | TABLET | ||||||
| 126195902 | 12619590 | 10 | SS | DASATINIB | DASATINIB | 1 | Oral | 100 MG, UNK | U | 0 | 100 | MG | TABLET | ||||||
| 126195902 | 12619590 | 11 | SS | METHOTREXATE. | METHOTREXATE | 1 | Intradiscal (intraspinal) | UNK | U | 0 | INJECTION | ||||||||
| 126195902 | 12619590 | 12 | SS | METHOTREXATE. | METHOTREXATE | 1 | Intradiscal (intraspinal) | 12 MG, 2X/WEEK | U | 0 | 12 | MG | INJECTION | BIW | |||||
| 126195902 | 12619590 | 13 | SS | CYTARABINE. | CYTARABINE | 1 | Intrameningeal | UNK | U | 0 | INJECTION | ||||||||
| 126195902 | 12619590 | 14 | SS | CYTARABINE. | CYTARABINE | 1 | Intrameningeal | 30 MG, 2X/WEEK | U | 0 | 30 | MG | INJECTION | BIW | |||||
| 126195902 | 12619590 | 15 | SS | HYDROCORTISONE SODIUM PHOSPHATE | HYDROCORTISONE SODIUM PHOSPHATE | 1 | Intrameningeal | UNK | U | 0 | INJECTION | ||||||||
| 126195902 | 12619590 | 16 | SS | HYDROCORTISONE SODIUM PHOSPHATE | HYDROCORTISONE SODIUM PHOSPHATE | 1 | Intrameningeal | 25 MG, 2X/WEEK | U | 0 | 25 | MG | INJECTION | BIW | |||||
| 126195902 | 12619590 | 17 | C | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 0 | |||||||||||
| 126195902 | 12619590 | 18 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | 0 | ||||||||||||
| 126195902 | 12619590 | 19 | C | CEFEPIME HYDROCHLORIDE. | CEFEPIME HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | INJECTION | ||||||||||
| 126195902 | 12619590 | 20 | C | AMIKACIN SULFATE. | AMIKACIN SULFATE | 1 | 0 | INJECTION | |||||||||||
| 126195902 | 12619590 | 21 | C | AMPHOTERICIN B. | AMPHOTERICIN B | 1 | 3 MG/KG, UNK | 0 | 3 | MG/KG | |||||||||
| 126195902 | 12619590 | 22 | C | AMPHOTERICIN B. | AMPHOTERICIN B | 1 | 5 MG/KG, UNK | 0 | 5 | MG/KG | |||||||||
| 126195902 | 12619590 | 23 | C | AMPHOTERICIN B. | AMPHOTERICIN B | 1 | 3 MG/KG, UNK | 0 | 3 | MG/KG | |||||||||
| 126195902 | 12619590 | 24 | C | AMPHOTERICIN B. | AMPHOTERICIN B | 1 | 2 MG/KG, UNK | 0 | 2 | MG/KG | |||||||||
| 126195902 | 12619590 | 25 | C | MEROPENEM. | MEROPENEM | 1 | Intravenous drip | 0 | INJECTION | ||||||||||
| 126195902 | 12619590 | 26 | C | VORICONAZOLE. | VORICONAZOLE | 1 | 0 | ||||||||||||
| 126195902 | 12619590 | 27 | C | LENOGRASTIM | LENOGRASTIM | 1 | 0 | INJECTION | |||||||||||
| 126195902 | 12619590 | 28 | C | CEFAZOLIN SODIUM. | CEFAZOLIN SODIUM | 1 | 0 | INJECTION | |||||||||||
| 126195902 | 12619590 | 29 | C | TEICOPLANIN | TEICOPLANIN | 1 | Intravenous drip | 0 | INJECTION | ||||||||||
| 126195902 | 12619590 | 30 | C | TACROLIMUS. | TACROLIMUS | 1 | 0 | ||||||||||||
| 126195902 | 12619590 | 31 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
| 126195902 | 12619590 | 32 | C | DORIPENEM | DORIPENEM | 1 | Intravenous drip | 0 | INJECTION | ||||||||||
| 126195902 | 12619590 | 33 | C | BIAPENEM | BIAPENEM | 1 | Intravenous drip | 0 | INJECTION | ||||||||||
| 126195902 | 12619590 | 34 | C | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 0 | INJECTION | ||||||||||
| 126195902 | 12619590 | 35 | C | LINEZOLID. | LINEZOLID | 1 | 0 | ||||||||||||
| 126195902 | 12619590 | 36 | C | PAZUFLOXACIN MESILATE | PAZUFLOXACIN MESILATE | 1 | Intravenous drip | 0 | INJECTION | ||||||||||
| 126195902 | 12619590 | 37 | C | CLINDAMYCIN PHOSPHATE. | CLINDAMYCIN PHOSPHATE | 1 | 0 | ||||||||||||
| 126195902 | 12619590 | 38 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 0 | ||||||||||||
| 126195902 | 12619590 | 39 | C | FOSCARNET SODIUM. | FOSCARNET SODIUM | 1 | Intravenous drip | 0 | INJECTION | ||||||||||
| 126195902 | 12619590 | 40 | C | HUMAN NORMAL IMMUNOGLOBULIN | HUMAN IMMUNOGLOBULIN G | 1 | 0 | INJECTION | |||||||||||
| 126195902 | 12619590 | 41 | C | ANTITHYMOCYTE IMMUNOGLOBULIN | THYMOCYTE IMMUNE GLOBULIN NOS | 1 | Intravenous (not otherwise specified) | 0 | INJECTION | ||||||||||
| 126195902 | 12619590 | 42 | C | METHYLPREDNISOLONE SODIUM SUCCINATE. | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Intravenous (not otherwise specified) | 0 | INJECTION | ||||||||||
| 126195902 | 12619590 | 43 | C | CICLOSPORIN | CYCLOSPORINE | 1 | 0 | ||||||||||||
| 126195902 | 12619590 | 44 | C | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126195902 | 12619590 | 1 | Acute lymphocytic leukaemia |
| 126195902 | 12619590 | 2 | Acute lymphocytic leukaemia |
| 126195902 | 12619590 | 3 | Acute lymphocytic leukaemia |
| 126195902 | 12619590 | 4 | Acute lymphocytic leukaemia |
| 126195902 | 12619590 | 6 | Acute lymphocytic leukaemia |
| 126195902 | 12619590 | 7 | Acute lymphocytic leukaemia |
| 126195902 | 12619590 | 9 | Acute lymphocytic leukaemia |
| 126195902 | 12619590 | 11 | Acute lymphocytic leukaemia |
| 126195902 | 12619590 | 13 | Acute lymphocytic leukaemia |
| 126195902 | 12619590 | 15 | Acute lymphocytic leukaemia |
| 126195902 | 12619590 | 17 | Infection prophylaxis |
| 126195902 | 12619590 | 18 | Infection prophylaxis |
| 126195902 | 12619590 | 19 | Febrile neutropenia |
| 126195902 | 12619590 | 20 | Febrile neutropenia |
| 126195902 | 12619590 | 30 | Prophylaxis against graft versus host disease |
| 126195902 | 12619590 | 31 | Prophylaxis against graft versus host disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126195902 | 12619590 | HO |
| 126195902 | 12619590 | OT |
| 126195902 | 12619590 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126195902 | 12619590 | Blood creatinine increased | |
| 126195902 | 12619590 | Encephalitis | |
| 126195902 | 12619590 | Febrile neutropenia | |
| 126195902 | 12619590 | Graft versus host disease | |
| 126195902 | 12619590 | Human herpesvirus 6 infection | |
| 126195902 | 12619590 | Hypokalaemia | |
| 126195902 | 12619590 | Mucormycosis | |
| 126195902 | 12619590 | Neutropenia | |
| 126195902 | 12619590 | Pneumonia | |
| 126195902 | 12619590 | Pseudomonas infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |